Category Archives: Uncategorized

The following are my comments published online within a very elaborate and long draft proposed plan by a climate commission on the island of Hawai’i island to the County of Hawaiʻi Planning Department. You may use my comments to respond … Continue reading →

United Nations Intergovernmental Panel on Climate Change (IPCC) reports, such as the recent 6th Assessment Report (AR6) and the six previous AR’s, as well as the 16 or 17 annual Friedlingstein et al (CDIAC and ESSD) reports, and reports by … Continue reading →

GOP lawmakers raise concerns about WHO’s Pandemic Preparedness Treaty, US involvement in agency In calling for the U.S. to end its membership in and financing of the WHO, the Sovereignty Coalition has issued a Declaration of their concerns and a … Continue reading →

Christine Anderson, MEP, of Germany 100% agree with her. God speed.

Dear Dr . Hoesung Lee, With the recently published Synthesis Report, the IPCC has completed its sixth assessment cycle, comprising a total of seven reports. An international team of scientists from the 1,500-strong Climate Intelligence Foundation (Clintel) has reviewed several claims from the Working Group 1 ( The Physical Science Basis ) … Continue reading →

“We engineered SARS.” “A biological warfare enabling technology.” “Since 2005.” Much more.

A new Rasmussen Reports survey reveals that a majority of Americans believe the media favors Democrats and is “truly the enemy of the people.” The survey was conducted May 16-18, 2023 from 1,002 U.S. likely voters. The survey also reveals that 59% … Continue reading →

Excellent. Well done. Professional. 1.5 hours. Free for now. Be informed. This is important. More “vaccines” are coming. Latest. The link to this documentary was removed or re-directed. Sorry for the trouble.

“If the American people ever allow private banks to control the issue of their money, first by inflation and then by deflation, the banks and corporations that will grow up around them (around the banks), will deprive the people of … Continue reading →

This is about 2 hours.  It starts with about 20 minutes of related news.  If you want to skip that news, go to ~20 minutes and begin the interview with Sasha Latypova, a retired biopharm R&D executive.  This is excellent. … Continue reading →